Brand Name
Renacidin
Generic Name
Gluconolactone
View Brand Information FDA approval date: February 01, 2016
Classification: Anti-coagulant
Form: Solution
What is Renacidin (Gluconolactone)?
Renacidin is indicated for dissolution of bladder calculi of the struvite or apatite variety by local intermittent irrigation through a urethral catheter or cystostomy tube as an alternative or adjunct to surgical procedures. Renacidin is also indicated for use as an intermittent irrigating solution to prevent encrustations of indwelling urethral catheters and cystostomy tubes.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment